NRX Pharmaceuticals, Inc. Common Stock

NRXP XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

170M

Short interest (May 15)

14.1%

Net Short (Jun 03 ): 0.7%

Borrow Fee

6.89%

↓ 1.4%

Available Shares

20K

↓ 9.1%

Price Chart

Company Overview

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001719406

Asset Type: CS

Market Data

Market Cap: $167,377,943

Employees: 29

Status: Active

Short Interest

Current Borrow Fee 6.89%

Range: 6.88% - 7.39%

Available Shares 20K

Range: 1K - 250K

Recent Changes

Fee Change: ↑ 6.7%

Available Change: ↓ 55.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime